Tech

Moderna Inc.’s CEO said the company doesn’t plan to invest in new late-stage vaccine trials due to growing opposition to immunizations from US officials

Posted on

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Exit mobile version